ARS Pharmaceuticals
SPRY
SPRY
187 hedge funds and large institutions have $1.04B invested in ARS Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 58 increasing their positions, 56 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
4% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 56
3% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 33
1% less funds holding
Funds holding: 188 → 187 (-1)
Holders
187
Holding in Top 10
2
Calls
$4.56M
Puts
$4.04M
Top Buyers
| 1 | +$30.8M | |
| 2 | +$19.4M | |
| 3 | +$16.5M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$15.1M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$7.88M |
Top Sellers
| 1 | -$25.1M | |
| 2 | -$13.1M | |
| 3 | -$10.4M | |
| 4 |
EP
Eversept Partners
New York
|
-$7.05M |
| 5 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$5.95M |
